References
[1] Gershon AS, Guan J, Wang C, et al. Describing and quantifying asthma comorbidity:a population study[J]. PLoS One, 2012, 7(5):e34967.
[2] 陈欣, 林江涛. 我国支气管哮喘防治现状[J]. 内科急危重症 杂志, 2008, 14(5):225-226.
[3] 全国儿科哮喘协作组. 第三次中国城市儿童哮喘流行病学调 查[J]. 中华儿科杂志, 2013, 51(10):729-735.
[4] Halwani R, Al-Muhsen S, Hamid Q. Airway remodeling in asthma[J]. Curr Opin Pharmacol, 2010, 10(3):236-245.
[5] Bergeron C, Al-Ramli W, Hamid Q. Remodeling in asthma[J]. Proc Am Thorac Soc, 2009, 6(3):301-305.
[6] Valentin ED, Crahay C, GarbackiN, et al. New asthma biomarkers:lessons from murine models of acute and chronic asthma[J]. Physiol Lung Cell M olPhysiol, 2009, 296(2):185-197.
[7] Kay AB. Allergy and allergic diseases[J]. N Eng I J Med, 2001, 344(1):30-37.
[8] Van Oosterhout AJ, Motta AC. Th1/Th2 paradigm:not seeing the forest for the trees?[J]. Eur Respir J, 2005, 25(4):591-593.[9] Choi IS. Immune tolerance by induced regulatory T cells in asthma[J]. Allergy Asthma Immunol Res[J]. 2012, 4(3):113-115.
[10] Veldhoen M, Hocking RJ, Atkins CJ, et a1. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells[J]. Immunity, 2006, 24(2):179-189.
[11] 姚斌, 李敏, 庞英. 草分枝杆菌对哮喘小鼠CD4+CD25+ 调节 性T 细胞和Th17 细胞平衡的影响[J]. 中国当代儿科学杂志, 2013, 15(11):1018-1022.
[12] 王绍斌, 沈华浩. 支气管哮喘小鼠气道重塑过程的动态观察[C]. 济南:中华医学会第七次全国呼吸病学术会议, 2006.
[13] Temelkovski J, Hogan SP, Shepherd DP, et al. An improved murine model of asthma:selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen[J]. Thorax, 1998, 53(10):849-856.
[14] 陈跃华, 朱华芳, 范婷婷. 哮喘患儿CD4+CD25+ T 细胞Foxp3 表达的意义[J]. 实用儿科临床杂志, 2007, 22(9):657-658.
[15] Xue K, Zhou Y, Xiong S, et al. Analysis of CD4+ CD25+ regulatory T cells and Foxp3 mRNA in the peripheral blood of patients with asthma[J]. J Huazhong Univ Sci Technolog, 2007, 27(1):31-33.
[16] Zu Y, Li CR, Zheng YJ, et al. The role of CD4+CD25+ regulatory T cells in the pathogenesis of asthma in children[J]. Zhonghua Yi Xue Za Zhi, 2006, 86(1):35-38.
[17] 李敏, 宋丽, 张剑波, 等. 哮喘患儿CD4+ CD25+ Treg 细胞及 IL-10 和TGF-β1 的变化[J]. 中国当代儿科杂志, 2009, 11(10):829-832.
[18] 庞英, 李敏, 张剑波, 等. 糖皮质激素对CD4+ CD25+ 调节 性T 细胞和TLR4 表达的影响[J]. 实用医院临床杂志, 2012, 1(9):60-62.
[19] Jones CE, Chan K. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine[J]. Am J Respir Cell Mol Biol, 2002, 26(6):748-753.
[20] Oboki K, Ohno T, Saito H, et al. Th17 and allergy[J]. Allergol Int, 2008, 57(2):121-34.
[21] Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine[J]. Respir Med, 2003, 97(6):726-733.
[22] Kearley J, Barker JE, Robinson DS, et al. Resolution of airway inflammation and hyperreactivity after in vivo transfer ofCD4+CD25+ regulatory T cells is interleukin 10 dependent[J]. ExpMed, 2005, 202(11):1539-1547.
[23] Kearley J, Robinson DS, Lloyd CM. CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling[J]. Allergy Clin Immunol, 2008, 122(3):617-624.
[24] Lauren EM, Ammon-Treiber S, Mothes B, et al. Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism[J]. J Clin Invest, 2013, 123(3):1216-1228.
[25] Donaldson DS, Apostolaki M, Bone HK, et al. The Escherichia coli heat-labile enterotoxin B subunit protects from allergic airway disease development by inducing CD4+ regulatory T cells[J]. Mucosal Immunol, 2013, 6(3):535-546.
[26] 黄花荣, 刘甜甜, 麦贤弟, 等. 哮喘患儿外周血CD4+CD25+ 调节性T细胞的变化及其与哮喘病情的关系[J]. 新医学, 2009, 40(4):221-223.
[27] Bulek K, Caini Liu, Swaidani S, et al. The inducible kinase IKKi is required for interleukin 17-dependent signaling associated with neutrophilia and pulmonary inflammation[J]. Nat Immunol, 2011, 12(9):844-852.
[28] Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines[J]. J Allergy Clin Immunol, 2001, 108(3):430-438.
[29] Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expression in nasal polyps:relation ship to collagen deposition and suppression by intranasal fluticasone propionate[J]. Laryngoscope, 2003, 113(10):1803-1812.
[30] Wang Q, Li H, Yao Y, et al. The overexpression of heparinbinding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model[J]. J Immunol, 2010, 185(2):834-841.
[31] Zhao J, Lloyd CM, Noble A. Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling[J]. Mucosal Immunol, 2013, 6(2):335-346.